Pre-Existing Antibodies within Immunogenicity Testing

Monoclonal antibodies and next-generation molecules such as antibody-drug conjugates (ADC) are being developed and moved into early-phase clinical testing. In this study, we detect Pre-Existing Antibodies (PEXA) using a homogenous MesoScale assay.

"*" indicates required fields

First Name*

Last Name*

Company*

State*

Country

Email*

Phone*

Please only hit the submit button once.

I AGREE*

By submitting this form I agree that Frontage may process my data in the manner described in Frontage’s Privacy Policy.

Name

This field is for validation purposes and should be left unchanged.

Pre-Existing Antibodies within Immunogenicity Testing

Resources to Consider

Assessing Pre-Existing Antibodies (PEXA) in Biotherapeutic Development

Evaluating the feasibility of lyophilization for oral formulation...

A Competitive Ligand-binding Assay for the Detection of Neutralizing...

Biologics Analytical Testing Services

Cell-Free DNA NGS Testing

Testing of Carryover & After MRD Benchtop Stability for...

GMP Analytical Testing in Gene Therapy Products

Guidelines for Developmental and Reproductive Toxicity (DART) Testing

Tissue IHC: from R&D to Clinical Lab Testing

Microbiological Testing Considerations for Pharmaceutical Products

Metabolites in Safety Testing (MIST): Analytical Strategy

Stability Testing